Skip to main content

Peer Review reports

From: In silico discovery of a novel potential allosteric PI3Kα inhibitor incorporating 2-oxopropyl urea targeting head and neck squamous cell carcinoma

Original Submission
24 Apr 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Jun 2024 Author responded Author comments - Wenqing Jia
Resubmission - Version 4
24 Jun 2024 Submitted Manuscript version 4
8 Aug 2024 Reviewed Reviewer Report
11 Sep 2024 Reviewed Reviewer Report
13 Sep 2024 Reviewed Reviewer Report
15 Sep 2024 Reviewed Reviewer Report
19 Dec 2024 Author responded Author comments - Wenqing Jia
Resubmission - Version 5
19 Dec 2024 Submitted Manuscript version 5
8 Jan 2025 Reviewed Reviewer Report
16 Jan 2025 Author responded Author comments - Wenqing Jia
Resubmission - Version 6
16 Jan 2025 Submitted Manuscript version 6
24 Jan 2025 Author responded Author comments - Wenqing Jia
Resubmission - Version 7
24 Jan 2025 Submitted Manuscript version 7
12 Feb 2025 Author responded Author comments - Wenqing Jia
Resubmission - Version 8
12 Feb 2025 Submitted Manuscript version 8
Publishing
13 Feb 2025 Editorially accepted
28 Feb 2025 Article published 10.1186/s13065-025-01420-6

You can find further information about peer review here.

Back to article page